Aplidin, plitidepsin, as PM90001 | PharmaMar
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study - Annals of Oncology
Aplidin™ induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C δ | Oncogene
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Of 72 antivirals tested in the laboratory, plitidepsin proves to be the most effective in preventing SARS-CoV-2 replication | IrsiCaixa
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™ | British Journal of Cancer
Plitidepsin (Aplidin) targets tumor-associated Nurse-Like cells (NLCs).... | Download Scientific Diagram
Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma | Future Oncology
Marine Drugs | Free Full-Text | Antitumor Peptides from Marine Organisms | HTML
Molecules | Free Full-Text | Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective | HTML
Phamamar achieve to extend the comercialization of its marine derived anti cancer drugs over eleven latinamerican countries.
Plitidepsin: design, development, and potential place in therapy | DDDT
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin - Taddei - 2006 - International Journal of Cancer - Wiley Online Library
Plitidepsin: design, development, and potential place in therapy | DDDT
Dehydrodidemnin B - an overview | ScienceDirect Topics
AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK* - Journal of Biological Chemistry
Oncology clinical pipeline marine inspired drugs | PharmaMar
Role of Cu 2+ in Aplidin s -induced apoptosis in MDA-MB-231 cells | Download Table
Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity | Leukemia
Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts. - Abstract - Europe PMC
JPM | Free Full-Text | Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19 | HTML
Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study - ScienceDirect
Plitidepsin | C57H87N7O15 - PubChem
Dehydrodidemnin B - an overview | ScienceDirect Topics
